美国对印度药品征收的关税引发市场下跌和贸易关切。 U.S. tariffs on Indian pharmaceuticals spark market drop and trade concerns.

印度股市在2025年9月26日下跌, 因为在美国宣布自10月1日起对品牌专利药品进口征收100%的关税后, 药店股票损失了。 Indian equity markets declined on September 26, 2025, as pharma stocks led losses following a U.S. announcement of a 100% tariff on branded patented pharmaceutical imports, effective October 1. Sensex和Nifty下跌,Sun Pharma和其他主要毒品制造者在对出口竞争力的担忧下急剧下降。 The Sensex and Nifty dropped, with Sun Pharma and other major drugmakers falling sharply amid concerns over export competitiveness. 这一举动是美国针对印度货物(包括卡车、家具和纺织品)的更广泛贸易措施的一部分,尽管对印度非专利药物出口的影响有限,但却引发了投资者的焦虑。 The move, part of broader U.S. trade measures targeting Indian goods including trucks, furniture, and textiles, sparked investor anxiety despite limited impact on India’s generic drug exports. 分析家注意到对关税范围的不确定性,特别是关于复杂的非专利商品,同时警告印度出口商可能受到经济后果的影响。 Analysts noted uncertainty over the tariff’s scope, particularly regarding complex generics, while warning of potential economic fallout for Indian exporters.